BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2900426)

  • 1. Triptorelin to prevent hysterectomy in patients with leiomyomas.
    van Leusden HA
    Lancet; 1988 Aug; 2(8609):508. PubMed ID: 2900426
    [No Abstract]   [Full Text] [Related]  

  • 2. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
    Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
    Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
    Filicori M; Hall DA; Loughlin JS; Rivier J; Vale W; Crowley WF
    Am J Obstet Gynecol; 1983 Nov; 147(6):726-7. PubMed ID: 6356927
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of chronic gonadotropin-releasing hormone analog (D-Trp-6) treatment on elevated and normal serum prolactin levels.
    Golan A; Bukovsky I; Weinraub Z; Ron-El R; Herman A; Raziel A; Caspi E
    Fertil Steril; 1989 Mar; 51(3):532-4. PubMed ID: 2522065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH.
    van Leusden HA
    Lancet; 1986 Nov; 2(8517):1213. PubMed ID: 2877341
    [No Abstract]   [Full Text] [Related]  

  • 7. Complication of triptorelin treatment for uterine myomas.
    Ellenbogen A; Shulman A; Libal Y; Jaschevatzky O; Anderman S; Grunstein S
    Lancet; 1989 Jul; 2(8655):167-8. PubMed ID: 2567943
    [No Abstract]   [Full Text] [Related]  

  • 8. D-Trp-6-luteinizing hormone-releasing hormone microcapsules in the treatment of uterine leiomyomas.
    Golan A; Bukovsky I; Schneider D; Ron-el R; Herman A; Caspi E
    Fertil Steril; 1989 Sep; 52(3):406-11. PubMed ID: 2528476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone (GnRH) action on uterine leiomyomata is not mediated by uterine GnRH receptors.
    Neuman M; Langer R; Golan A; Bukovsky I; Caspi E; Koch Y
    Fertil Steril; 1991 Aug; 56(2):364-6. PubMed ID: 1649060
    [No Abstract]   [Full Text] [Related]  

  • 10. Hormonal therapy before surgical treatment for uterine leiomyomas.
    Moghissi KS
    Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonists: utilization before hysterectomy.
    Stovall TG
    Clin Obstet Gynecol; 1993 Sep; 36(3):642-9. PubMed ID: 8403610
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of uterine fibroids with agonist analogs of gonadotropin-releasing hormone.
    Kessel B; Liu J; Mortola J; Berga S; Yen SS
    Fertil Steril; 1988 Mar; 49(3):538-41. PubMed ID: 3277869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone.
    Perl V; Marquez J; Schally AV; Comaru-Schally AM; Leal G; Zacharias S; Gomez-Lira C
    Fertil Steril; 1987 Sep; 48(3):383-9. PubMed ID: 2957235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-surgical treatment of uterine myomas with LH-RH agonists.
    D'Addato F; Repinto A; Andreoli C
    Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas.
    Stovall TG; Ling FW; Henry LC; Woodruff MR
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1420-3; discussion 1423-5. PubMed ID: 1904681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid reduction of uterine leiomyomas with monthly injections of D-Trp6-GnRH.
    van Leusden HA; Dogterom AA
    Gynecol Endocrinol; 1988 Mar; 2(1):45-51. PubMed ID: 2972173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of routine gonadotropin releasing hormone agonist treatment before abdominal hysterectomy for leiomyoma.
    Balasch J; Manau D; Mimó J; Duran M; Puerto B; Vanrell JA
    Acta Obstet Gynecol Scand; 1995 Aug; 74(7):562-5. PubMed ID: 7618457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of decapeptyl (D-TrpG GnPh) on estrogen receptors, progesterone receptors and tissue levels of estrogens (non-conjugated and sulfate-conjugated) in patients with uterine myoma].
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Pathol Biol (Paris); 1990 Nov; 38(9):941-3. PubMed ID: 2148976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroids (uterine myomatosis, leiomyomas).
    Lethaby A; Vollenhoven B
    Clin Evid; 2005 Dec; (14):2264-82. PubMed ID: 16620489
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
    Pasqualini JR; Cornier E; Grenier J; Vella C; Schatz B; Netter A
    Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.